跳到正文
Molence· @MolenceBio · X·· 17 天前AI 评分62
AI 导读

Molence Bio 报告 30 个零样本 BCMA 设计产生 12 个结合命中,两个候选以 VHH-Fc 融合体测试得到 43 pM 和 1.1 nM 的 SPR KD 值。这两个候选结合细胞表面 BCMA 的 EC50 为 0.19 和 0.16 nM,同一实验中的 belantamab 为 4.1 nM。

正文 · 原文

4/15 🎯 43 pM affinity from zero-shot BCMA designs.

Thirty designs yielded 12 binding hits. Two selected candidates, tested as VHH-Fc fusions, achieved SPR KD values of 43 pM and 1.1 nM.

They also bound cell-surface BCMA: EC50 values were 0.19 and 0.16 nM, versus 4.1 nM for belantamab in the same assay.

These experiments connect de novo antibody design to biochemical affinity and recognition of a target on cells.

#ProteinDesign

来源:Molence · x.com